Seltzer MA - Search Results

1

Evaluating tumor biology and oncological disease with positron-emission tomography.

Silverman DH, Hoh CK, Seltzer MA, Schiepers C, Cuan GS, Gambhir SS, Zheng L, Czernin J, Phelps ME. Silverman DH, et al. Among authors: seltzer ma. Semin Radiat Oncol. 1998 Jul;8(3):183-96. doi: 10.1016/s1053-4296(98)80044-1. Semin Radiat Oncol. 1998. PMID: 9634495 Review.

2

PET in oncology: will it replace the other modalities?

Hoh CK, Schiepers C, Seltzer MA, Gambhir SS, Silverman DH, Czernin J, Maddahi J, Phelps ME. Hoh CK, et al. Among authors: seltzer ma. Semin Nucl Med. 1997 Apr;27(2):94-106. doi: 10.1016/s0001-2998(97)80042-6. Semin Nucl Med. 1997. PMID: 9144854 Review.

3

Positron emission tomography in urological oncology.

Hoh CK, Seltzer MA, Franklin J, deKernion JB, Phelps ME, Belldegrun A. Hoh CK, et al. Among authors: seltzer ma. J Urol. 1998 Feb;159(2):347-56. doi: 10.1016/s0022-5347(01)63916-8. J Urol. 1998. PMID: 9649238 Review.

4

Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer.

Seltzer MA, Barbaric Z, Belldegrun A, Naitoh J, Dorey F, Phelps ME, Gambhir SS, Hoh CK. Seltzer MA, et al. J Urol. 1999 Oct;162(4):1322-8. J Urol. 1999. PMID: 10492189 Clinical Trial.

5

ROC and localization ROC analyses of lesion detection in whole-body FDG PET: effects of acquisition mode, attenuation correction and reconstruction algorithm.

Farquhar TH, Llacer J, Hoh CK, Czernin J, Gambhir SS, Seltzer MA, Silverman DH, Qi J, Hsu C, Hoffman EJ. Farquhar TH, et al. Among authors: seltzer ma. J Nucl Med. 1999 Dec;40(12):2043-52. J Nucl Med. 1999. PMID: 10616885 Free article.

6

Characterization of hilar lymph node by 18F-fluoro-2-deoxyglucose positron emission tomography in healthy subjects.

Kwan A, Seltzer M, Czernin J, Chou MJ, Kao CH. Kwan A, et al. Anticancer Res. 2001 Jan-Feb;21(1B):701-6. Anticancer Res. 2001. PMID: 11299829

7

Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective.

Meta J, Seltzer M, Schiepers C, Silverman DH, Ariannejad M, Gambhir SS, Phelps ME, Valk P, Czernin J. Meta J, et al. J Nucl Med. 2001 Apr;42(4):586-90. J Nucl Med. 2001. PMID: 11337546 Free article.

8

Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective.

Yap CS, Seltzer MA, Schiepers C, Gambhir SS, Rao J, Phelps ME, Valk PE, Czernin J. Yap CS, et al. Among authors: seltzer ma. J Nucl Med. 2001 Sep;42(9):1334-7. J Nucl Med. 2001. PMID: 11535721 Free article.

9

The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer.

Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, Czernin J. Safaei A, et al. Clin Nephrol. 2002 Jan;57(1):56-62. doi: 10.5414/cnp57056. Clin Nephrol. 2002. PMID: 11837802

10

The impact of PET on the management of lung cancer: the referring physician's perspective.

Seltzer MA, Yap CS, Silverman DH, Meta J, Schiepers C, Phelps ME, Gambhir SS, Rao J, Valk PE, Czernin J. Seltzer MA, et al. J Nucl Med. 2002 Jun;43(6):752-6. J Nucl Med. 2002. PMID: 12050318 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters